Data Advisory Board
The Data Advisory Board advises us on the development and delivery of our Research Data Strategy.
Through this strategy, we aim to realise the potential of the cancer research data that we fund through improved data sharing and data science approaches. Together we will create a research data ecosystem that best serves cancer research for the benefit of patients and the public.
Remit of the board
This board is a group of international experts who bring a unique perspective on oncology data science, including trends and advances. They help us to consider the unique role that Cancer Research UK can play in this space with advice spanning a wide range of topics and activities relevant to our work in research data, such as:
- current and future data programmes and funding streams
- computing and infrastructure
- research data findability, accessibility, interoperability and reusability
- training, careers and research capacity to carry out quality data science
- patient and public involvement and engagement
- therapeutic translation
- community and culture
- sustainability, including environmental
- equality, diversity and inclusion
Members of the board
Bissan Al-Lazikani
Chair
Professor of Genomic Medicine
Director of Therapeutics Data Science, The University of Texas MD Anderson Cancer Center, USA
Hugo Aerts
Director of Artificial Intelligence in Medicine Program, Harvard University
Associate Professor, Harvard University, Dana-Farber Cancer Institute and Massachusetts General Brigham Hospital, USA
Full Professor, Maastricht University, Netherlands
Chris Carrigan
Patient Representative
Expert Data Adviser, use MY data
Michael Chapman
Director of Research and Clinical Trials, NHS England
Michael Cuthbert
Director, UK National Quantum Computing Centre
David Ford
Professor of Informatics and Director of Population Data Science, Swansea University
Lead, SAIL Databank
Director, Administrative Data Research UK’s Centre for Wales
Chris Holmes
Professor of Biostatistics, University of Oxford
Debbie Keatley
Patient Member, Cancer Research UK’s Clinical Research Committee and Experimental Medicine Expert Review Panel
Member, Health Data Research UK’s Public Advisory Board
Martin Levermore
Founder and Chief Executive, MDTi
Commercial Advisor, PIONEER
Non-Executive Director and Chair of Digital, Implementation and Research, Royal Wolverhampton NHS Trust
Senior Association, Royal Society of Medicine
Visiting Professor for Health, Education and Life Sciences, Birmingham City University
UK Home Office Independent Person to advise on the Windrush Compensation Scheme
Parker Moss
Executive Vice President Corporate Development, Exscientia
Non-Executive Director, Cancer Research Horizons
Michael Parker
Ethox Centre Director and Professor of Bioethics, University of Oxford
Ethics Lead, Our Future Health
Cathie Sudlow
Director, MRC’s Adolescent Health Study
Professor of Neurology and Clinical Epidemiology, University of Edinburgh
Honorary Consultant Neurologist, NHS Lothian (acute stroke service)
Data-driven cancer research conference
Join us on 27-28 February, 2024 for our inaugural data-driven cancer research conference to celebrate the potential of cancer research data to drive discovery and innovation.